UNSPSC 51272400: Anaesthetic ethers

Anaesthetics based on compounds that contain an ether group, where two hydrocarbon groups are linked by an oxygen atom, such as two alkyl or aryl groups plus oxygen.

UNSPSC 51272400 Anaesthetic ethers is a Class code covering pharmaceutical procurement for state and local health and human services operations. Recent state and local solicitations under this code show activity focused on emergency medical supplies, generic pharmaceuticals, and over-the-counter products distributed through established wholesaler networks and direct-to-manufacturer models. State health agencies and county health departments are the primary issuing bodies, purchasing naloxone and drug deactivation systems for community health initiatives, generic multi-source pharmaceuticals for statewide and multi-jurisdictional distribution, and exploring direct pharmacy benefit management programs to improve prescription fulfillment and cost control. The mix of solicitations reflects both tactical commodity procurement (recurring annual purchases of specific emergency medications) and strategic market intelligence gathering (vendor capability assessments for future contracting frameworks).

Recent activity spans Texas, Minnesota, Florida, and Oregon. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023; vendors must include all shipping costs and comply with E-Verify and drug-free workplace certification. The Texas Health and Human Services Commission posted an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs that bypass traditional pharmacy benefit managers and wholesalers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, with products to be supplied through AmerisourceBergen, Cardinal Health, and Morris & Dickson; evaluation weights price competitiveness at 75 percent, with contract terms effective July 1, 2026, and incumbent renewals through June 30, 2028.